Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;96(1):8-11.
doi: 10.1016/j.ijgo.2006.09.017. Epub 2006 Dec 22.

Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease

S C Gilli  1 , E V De Paula, F P Biscaro, J F Marques, F F Costa, S T Saad
Affiliations

Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease

S C Gilli et al. Int J Gynaecol Obstet. 2007 Jan.

Abstract

Objective: To evaluate the effects of prophylactic transfusion by means of erythrocytapheresis at the beginning of the third trimester of pregnancy in women with sickle cell disease (SCD).

Methods: A cohort of 14 pregnant women with SCD who received prophylactic erythrocytapheresis transfusions at the beginning of the third trimester was retrospectively compared with a cohort of 17 pregnant women who received simple prophylactic transfusions for no indication other than SCD severity.

Results: Prophylactic erythrocytapheresis transfusions were associated with a lower risk of intrauterine growth restriction (OR, 0.11; 95% confidence interval, 0.01-1.00) and oligohydramnios (OR, 0.65; 95% confidence interval, 0.45-0.92) in pregnant women with SCD.

Conclusion: These results suggest that erythrocytapheresis transfusions are beneficial in women with SCD who are in the third trimester of pregnancy. Given the decrease in transfusion risks, this therapy deserves further evaluation in future trials.

PubMed Disclaimer

LinkOut - more resources